POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Colorado exempts FDA-approved and DEA-rescheduled prescription products containing schedule I substances from schedule I controls

Original title: Use of Prescription Product with Controlled Substance

Last action · April 20, 2026: Governor SignedSponsors: William Lindstedt and 16 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Colorado law now exempts certain prescription drug products containing controlled substances from schedule I restrictions, provided they are approved by the FDA, rescheduled by the DEA, dispensed by authorized entities, and possessed by authorized individuals. The exemption takes effect immediately upon DEA designation or rescheduling, requiring the state to control these products in the same manner as federal law.

Why it matters

Changes how specific prescription medications containing controlled substances are regulated under state criminal statutes, aligning state drug schedules with federal approvals for patients and practitioners.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Pharmacies and prescription drug outlets

Pharmacies and prescription drug outlets must dispense the qualifying prescription products according to the updated state and federal control standards.

Directly affected

Authorized practitioners

Authorized practitioners are permitted to administer the qualifying prescription drug products under the new exemption rules.

Directly affected

Persons authorized to possess a controlled substance

Individuals authorized to possess controlled substances may possess the exempted prescription products without schedule I restrictions.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Which prescription products are exempted from schedule I under this act?
Prescription drug products containing a controlled substance that are approved by the FDA, rescheduled by the DEA, dispensed by an authorized outlet or practitioner, and held by an authorized possessor.
Does this act affect marijuana or natural medicine regulations?
No, the act explicitly clarifies that its provisions do not apply to or affect the regulation of, or lawful actions concerning, natural medicine, natural medicine products, marijuana, or marijuana concentrate.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Signed into law.

Procedural history

16 actions
  1. Apr 20, 2026Office of the GovernorEnrolled
    Governor Signed
  2. Apr 8, 2026Office of the GovernorEnrolled
    Sent to the Governor
  3. Apr 7, 2026SenateFloor
    Signed by the President of the Senate
  4. Apr 7, 2026HouseFloor
    Signed by the Speaker of the House
  5. Apr 6, 2026Senate
    Senate Considered House Amendments - Result was to Concur - Repass
  6. Apr 2, 2026HouseFloor
    House Third Reading Passed - No Amendments
Show 10 earlier actions
  1. Mar 31, 2026House
    House Third Reading Laid Over Daily - No Amendments
  2. Mar 30, 2026House
    House Second Reading Special Order - Passed with Amendments - Committee
  3. Mar 25, 2026HouseCommittee
    House Committee on Health & Human Services Refer Amended to House Committee of the Whole
  4. Feb 25, 2026HouseIntroduced
    Introduced In House - Assigned to Health & Human Services
  5. Feb 24, 2026SenateFloor
    Senate Third Reading Passed - No Amendments
  6. Feb 23, 2026SenateFloor
    Senate Second Reading Passed with Amendments - Committee, Floor
  7. Feb 18, 2026Senate
    Senate Second Reading Laid Over to 02/23/2026 - No Amendments
  8. Feb 12, 2026SenateCommittee
    Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
  9. Feb 4, 2026Senate
    Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only
  10. Jan 22, 2026SenateIntroduced
    Introduced In Senate - Assigned to Health & Human Services

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Voting Record

Show 2 earlier roll calls
Motion succeededSenate2/12/2026Open StatesOfficial roll call ↗

Adopt amendment L.001 (Attachment A).

Total

2

Yes
0
No
0
Present
0
Not voting
0
Abstain
0
Other positions
2

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Colorado, United States food and drug administration, United States drug enforcement agency
locationColorado“State controlling the product in the same manner as the DEA”Map →
OrganizationUnited States food and drug administration“Approves prescription use of drug products”Map →
OrganizationUnited States drug enforcement agency“Designates or reschedules controlled substances”Map →

Sources

Open source document

leg.colorado.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy15
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record